Arch Therapeutics Inc Quick Ratio (ARTH) starting from the third quarter 2024 to third quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Arch Therapeutics Inc   (ARTH)

Arch Therapeutics Inc 's Quick Ratio

ARTH's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2024, Quick Ratio fell to 0 a new company low.

Within Medical Equipment & Supplies industry 199 other companies have achieved higher Quick Ratio than Arch Therapeutics Inc in third quarter 2024. While Quick Ratio total ranking in the third quarter 2024 has deteriorated compared to the prior quarter from 2112 to 4178.

Explain Quick Ratio?
How much Cash & cash equivalents ARTH´s has?
What are ARTH´s Current Liabilities?




ARTH Quick Ratio (Jun 30 2024)
Q3
(Mar 31 2024)
Q2
(Dec 31 2023)
Q1
(Sep 30 2023)
Q4
(Jun 30 2023)
Q3
Y / Y Current Liabilities Change 45.71 % 55.63 % 174.96 % 185.07 % 464.75 %
Y / Y Cash & cash equivalent Change -65.3 % -10.41 % -72.44 % -70.18 % 57.36 %
Quick Ratio MRQ 0 0 0.02 0.02 0.01
ARTH's Total Ranking # 4178 # 2112 # 1307 # 2117 # 4663
Seq. Current Liabilities Change 12.41 % 8.95 % 20.41 % -1.18 % 20.06 %
Seq. Cash & cash equivalent Change 13.64 % -87.16 % -7.57 % 157.35 % 193.41 %



Quick Ratio third quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 200
Healthcare Sector # 917
Overall Market # 4178


Quick Ratio Statistics
High Average Low
18.09 3.92 0
(Jun 30 2018)   (Mar 31 2024)




Financial Statements
Arch Therapeutics Inc 's Current Liabilities $ 14 Millions Visit ARTH's Balance sheet
Arch Therapeutics Inc 's Cash & cash equivalent $ 0 Millions Visit ARTH's Balance sheet
Source of ARTH's Sales Visit ARTH's Sales by Geography


Cumulative Arch Therapeutics Inc 's Quick Ratio

ARTH's Quick Ratio for the trailling 12 Months

ARTH Quick Ratio

(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
(Sep 30 2023)
12 Months
(Jun 30 2023)
12 Months
Y / Y Current Liabilities TTM Growth 88.78 % 150.05 % 267.67 % 287.02 % 287.33 %
Y / Y Cash & cash equivalent TTM Growth -69.87 % -65.69 % -66.03 % -44.17 % -53.53 %
Quick Ratio TTM 0.01 0.01 0.01 0.03 0.06
Total Ranking TTM # 3721 # 1664 # 1160 # 3709 # 3981
Seq. Current Liabilities TTM Growth 10.22 % 11.55 % 23.27 % 24.56 % 45.99 %
Seq. Cash & cash equivalent TTM Growth -10.44 % -0.56 % -49.84 % -32.56 % 2 %


On the trailing twelve months basis In Spite of the increase in Current Liabilities in the Q3 2024 to $13.96 millions, cumulative Quick Ratio remained unchanged at 0.01 below the Arch Therapeutics Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 222 other companies have achieved higher Quick Ratio than Arch Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2024 from 1664 to 3721.

Explain Quick Ratio?
How much Cash & cash equivalents ARTH´s has?
What are ARTH´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 223
Healthcare Sector # 984
Within the Market # 3721


trailing twelve months Quick Ratio Statistics
High Average Low
13.69 4.46 0.01
(Mar 31 2019)   (Jun 30 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2024, within Medical Equipment & Supplies Industry Quick RatioJun 30 2024 MRQ Cash & cash equivalentJun 30 2024 MRQ Current Liabilities
Catheter Precision Inc 0.00 $ 0.016  Millions$ 3.318  Millions
Therapeutic Solutions International Inc 0.00 $ 0.008  Millions$ 1.850  Millions
Vystar Corporation 0.00 $ 0.023  Millions$ 6.705  Millions
Yunhong Green Cti Ltd 0.00 $ 0.022  Millions$ 7.450  Millions
Arch Therapeutics Inc 0.00 $ 0.030  Millions$ 13.958  Millions
Assure Holdings Corp 0.00 $ 0.045  Millions$ 23.785  Millions
Northview Acquisition Corp 0.00 $ 0.006  Millions$ 4.157  Millions
United Health Products Inc 0.00 $ 0.003  Millions$ 2.091  Millions
Marizyme Inc 0.00 $ 0.035  Millions$ 38.550  Millions

Date modified: 2026-09-12T06:11:07+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.